281 related articles for article (PubMed ID: 15103216)
1. Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula.
Lee SC; Seong YS; Kim SS; Koh HJ; Kwon OW
Ophthalmologica; 2004; 218(3):193-201. PubMed ID: 15103216
[TBL] [Abstract][Full Text] [Related]
2. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.
Eandi CM; Ober MD; Freund KB; Slakter JS; Yannuzzi LA
Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
[TBL] [Abstract][Full Text] [Related]
4. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy.
Ladd BS; Solomon SD; Bressler NM; Bressler SB
Am J Ophthalmol; 2001 Nov; 132(5):659-67. PubMed ID: 11704027
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy.
Lai TY; Chan WM; Liu DT; Luk FO; Lam DS
Br J Ophthalmol; 2008 May; 92(5):661-6. PubMed ID: 18356265
[TBL] [Abstract][Full Text] [Related]
8. Polypoidal choroidal vasculopathy and retinochoroidal anastomosis in Japanese patients eligible for photodynamic therapy for exudative age-related macular degeneration.
Obata R; Yanagi Y; Kami J; Takahashi H; Inoue Y; Tamaki Y
Jpn J Ophthalmol; 2006; 50(4):354-360. PubMed ID: 16897221
[TBL] [Abstract][Full Text] [Related]
9. Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis.
Mauget-Faÿsse M; Mimoun G; Ruiz-Moreno JM; Quaranta-El Maftouhi M; De Laey JJ; Postelmans L; Soubrane G; Defauchy M; Leys A
Retina; 2006 Apr; 26(4):396-403. PubMed ID: 16603957
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment.
Saito M; Iida T; Nagayama D
Br J Ophthalmol; 2008 Dec; 92(12):1642-7. PubMed ID: 18782798
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy for age-related macular degeneration.
Jin C; Ge J; Zhou S; Chen H; Zhong X; Jiang R; Chen L; Chen L
Yan Ke Xue Bao; 2004 Sep; 20(3):158-62. PubMed ID: 15499723
[TBL] [Abstract][Full Text] [Related]
12. Role of photodynamic therapy in polypoidal choroidal vasculopathy.
Akaza E; Yuzawa M; Matsumoto Y; Kashiwakura S; Fujita K; Mori R
Jpn J Ophthalmol; 2007; 51(4):270-7. PubMed ID: 17660987
[TBL] [Abstract][Full Text] [Related]
13. [Photodynamic therapy for polypoidal choroidal vasculopathy].
You J; Guo X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):899-902. PubMed ID: 21946209
[TBL] [Abstract][Full Text] [Related]
14. Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy.
Hirami Y; Tsujikawa A; Otani A; Yodoi Y; Aikawa H; Mandai M; Yoshimura N
Retina; 2007 Mar; 27(3):335-41. PubMed ID: 17460589
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: results of a 1-year preliminary study.
Ruamviboonsuk P; Tadarati M; Vanichvaranont S; Hanutsaha P; Pokawattana N
Br J Ophthalmol; 2010 Aug; 94(8):1045-51. PubMed ID: 20530656
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy with verteporfin following transpupillary thermotherapy for CNV evolving from an initially occult to a predominantly classic form, in patients with AMD.
Hamon F; Goeminne P
Semin Ophthalmol; 2001 Dec; 16(4):223-32. PubMed ID: 15513445
[TBL] [Abstract][Full Text] [Related]
17. Incidence, outcomes, and risk factors for hemorrhagic complications in eyes with polypoidal choroidal vasculopathy following photodynamic therapy in Indian subjects.
Rishi P; Rishi E; Sharma M; Maitray A; Bhende M; Gopal L; Sharma T; Ratra D; Sen P; Bhende P; Rao C; Susvar P
Indian J Ophthalmol; 2017 Aug; 65(8):712-718. PubMed ID: 28820157
[TBL] [Abstract][Full Text] [Related]
18. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
Lazic R; Gabric N
Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
[TBL] [Abstract][Full Text] [Related]
19. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy.
Otani A; Sasahara M; Yodoi Y; Aikawa H; Tamura H; Tsujikawa A; Yoshimura N
Am J Ophthalmol; 2007 Jul; 144(1):7-14. PubMed ID: 17467649
[TBL] [Abstract][Full Text] [Related]
20. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
Schmidt-Erfurth UM; Michels S
Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
